Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-11-IDEX-0004-02)
Received: 11 January 2019
Accepted: 18 March 2019
First Online: 15 May 2019
Ethics approval and consent to participate
: This study is part of clinical trial C07-33 sponsored by Inserm. It was granted approval by local Ethics Committee or “Comité de Protection des Personnes” on 2008 November 14th, authorized by the French authorities (ANSM B80738-70 on 2008 August 11th), and registered in a public trial registry (NCT02628808). All study participants gave their informed written consent to participation, in line with French ethical guidelines.
: All authors agreed to this manuscript’s publication.
: Myriam Ly Le-Moal is an employee of the Roche Institute. The other authors report no biomedical financial interests or potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.